Annotated Medicine and Device Lists


Methotrexate

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
Bulbo.

This medicine is present in:

This medicine is present in:

List Section Observation
Peru 8.2 Cytotoxics No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti Metabolites Others observations:
IV AND INTRATHECAL USE
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti Metabolites No observations
Suriname. NGK-C-011 8.2 Cytotoxic Agents No observations

This medicine is present in:

List Section Observation
Peru 8.2 Cytotoxics No observations
El Salvador - 2019 ANTINEOPLASICOS: Antimetabolitos No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 AGENTES ANTINEOPLÁSICOS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
BULBO.INY IM,IV,IT,IA.BBO X 20ML
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTINEOPLÁSICOS No observations

This medicine is present in:

List Section Observation
Peru 8.2 Cytotoxics No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 AGENTES ANTINEOPLÁSICOS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 08.02 ANTIMETABOLITES No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTINEOPLÁSICOS No observations

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 08.02 Cytotoxic and adjuvant drugs No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 9.02.02. Antimetabolites No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti Metabolites No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 41. Antineoplásicos y agentes inmunomoduladores No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
sodico INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS DE ADMINISTRACIÓN PARENTERAL EN CONCENTRACIONES EQUIVALENTES A 5MG/0,1 ML
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 05.02. OTROS FARMACOS ANTIRREUMATICOS No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 18.01. FÁRMACOS CITOTÓXICOS No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 20.06. INMUNOSUPRESORES No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 8.2.1 Cytotoxic medicines No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 41. Antineoplásicos y agentes inmunomoduladores No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES No observations
El Salvador - 2019 ANTINEOPLASICOS: Antimetabolitos No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.01. CITOTOXICOS O ANTINEOPLASICOS No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 10:00 Anti-neoplastic agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 10.0 Antineoplastics No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti Metabolites No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 AGENTES ANTINEOPLÁSICOS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 100 TABLETAS.
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 09.03 IMMUNOSUPPRESSANTS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 L. AGENTES ANTINEOPLÁSICOS E IMUNOMODULADORES No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTINEOPLÁSICOS No observations
El Salvador - 2019 INMUNOMODULADORES No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.01. CITOTOXICOS O ANTINEOPLASICOS No observations
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use Others observations:
Reserved for specialist use.
Guyana. Essential Medicines List. 2020-2021 9.02.02. Antimetabolites No observations
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 10:00 Anti-neoplastic agents No observations
Suriname. NGK-C-011 2.4 Anti-gout agents and agents for Rheumatic diseases No observations
Haiti. National List of Essential Medicines 30.02. Disease modifying agents used in rheumatoid arthritis No observations
Haiti. National List of Essential Medicines 08.02 Cytotoxic and adjuvant drugs No observations
Barbados. Barbados National Drug Formulary (BNDF) 10.0 Antineoplastics No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 8.2.1 Cytotoxic medicines No observations
WHO Model List of Essential Medicines 2019 29.2 Disease-modifying agents used in rheumatoid disorders (DMARDs) No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines No observations
Peru 8.2 Cytotoxics No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 41. Antineoplásicos y agentes inmunomoduladores No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 08.02 ANTIMETABOLITES No observations
Chile. Formulario Nacional de Medicamentos. 2005 02.04. ANTIRREUMATICOS NO ESTEROIDALES No observations
Suriname. NGK-C-011 8.2 Cytotoxic Agents No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use Others observations:
Reserved for specialist use.
Guyana. Essential Medicines List. 2020-2021 9.02.02. Antimetabolites No observations
Guyana. Essential Medicines List. 2020-2021 Reserved for specialist use No observations

Information Resources: Methotrexate

Loading ...
Loading ...
Loading ...
No information available